P406 A novel active learning-based digital pathology protocol annotation for histologic assessment in Ulcerative Colitis using PICaSSO Histologic Remission Index (PHRI)
Giovanni Santacroce(Università Cattolica del Sacro Cuore), Enrico Grisan(University of Padua), Brian Hayes(Cork University Hospital), Valery Naranjo(Universitat Politècnica de València), R Crotty(Cork University Hospital), Rocío del Amor(Universitat Politècnica de València), Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust), I Zammarchi(APC Microbiome Institute), Subrata Ghosh(University College Cork), Pascual José Claramonte Meseguer(Generalitat Valenciana), Louise Burke(Cork University Hospital)
Cited by 8
Related Papers
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
|New England Journal of Medicine|2012|1.1k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
|Journal of Crohn s and Colitis|2021|540